# Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique

> **NCT02191527** · NA · COMPLETED · sponsor: **Elizabeth Glaser Pediatric AIDS Foundation** · enrollment: 1673 (actual)

## Conditions studied

- HIV
- Syphilis
- Anemia During Pregnancy

## Interventions

- **DEVICE:** PIMA® for quantitative analysis of CD4-count
- **DEVICE:** Hemocue® (HemoCue AB, Angelhom, Sweden) for quantitative analysis of hemoglobin
- **DEVICE:** SD Bioline® (Standard Diagnostics Inc., South-Korea) for qualitative analysis of syphilis

## Key facts

- **NCT ID:** NCT02191527
- **Lead sponsor:** Elizabeth Glaser Pediatric AIDS Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-10
- **Final completion:** 2015-02
- **Target enrollment:** 1673 (ACTUAL)
- **Last updated:** 2020-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191527, "Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02191527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*